10-Q/A XBRL

10-Q/A

Company: Aclaris Therapeutics, Inc.
Filed: December 3, 2015
Period of Report: September 30, 2015
Accession Number: 0001104659-15-082661

View Document ↗ View on SEC.gov ↗